Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer

http://www.rtog.org/ResearchAssociates/AdverseEventReporting/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf. Pavy, 1995, EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale, Radiother Oncol, 35, 11, 10.1016/0167-8140(95)97448-M Rubin, 1995, RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system, Int J Radiat Oncol Biol Phys, 31, 1041, 10.1016/0360-3016(95)00057-6 Haviland, 2008, Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancer, Clin Oncol (R Coll Radiol), 20, 497, 10.1016/j.clon.2008.03.017 Aaronson, 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology, J Natl Cancer Inst, 85, 365, 10.1093/jnci/85.5.365 Brady, 1997, Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument, J Clin Oncol, 15, 974, 10.1200/JCO.1997.15.3.974 Dolan, 1997, Modeling valuations for EuroQol health states, Med Care, 35, 1095, 10.1097/00005650-199711000-00002 Faithfull, 2015, Patient-reported outcome measures in radiotherapy: clinical advances and research opportunities in measurement for survivorship, Clin Oncol (R Coll Radiol), 27, 679, 10.1016/j.clon.2015.07.007 Basch, 2012, Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology, J Clin Oncol, 30, 4249, 10.1200/JCO.2012.42.5967 Rothman, 2007, Patient-reported outcomes: conceptual issues, Value Health, 10, S66, 10.1111/j.1524-4733.2007.00269.x Bentzen, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet Oncol, 9, 331, 10.1016/S1470-2045(08)70077-9 Hopwood, 2010, Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials, Lancet Oncol, 11, 231, 10.1016/S1470-2045(09)70382-1 Haviland, 2013, The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials, Lancet Oncol, 14, 1086, 10.1016/S1470-2045(13)70386-3 Bentzen, 2008, The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial, Lancet, 371, 1098, 10.1016/S0140-6736(08)60348-7 Sprangers, 1996, The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study, J Clin Oncol, 14, 2756, 10.1200/JCO.1996.14.10.2756 Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x Hopwood, 2001, A body image scale for use with cancer patients, Eur J Cancer, 37, 189, 10.1016/S0959-8049(00)00353-1 Bowker, 1948, A test for symmetry in contingency tables, J Am Stat Assoc, 43, 572, 10.1080/01621459.1948.10483284 Altman, 1991 Davidson, 2007, Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency, Int J Radiat Oncol Biol Phys, 69, 1218, 10.1016/j.ijrobp.2007.04.054 Vistad, 2008, Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?, Int J Radiat Oncol Biol Phys, 71, 1335, 10.1016/j.ijrobp.2007.12.030 Fromme, 2004, How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30, J Clin Oncol, 22, 3485, 10.1200/JCO.2004.03.025 Velikova, 2001, Self-reported quality of life of individual cancer patients: concordance of results with disease course and medical records, J Clin Oncol, 19, 2064, 10.1200/JCO.2001.19.7.2064 Gotay, 2009, Patient symptoms and clinician toxicity ratings: both have a role in cancer care, J Natl Cancer Inst, 101, 1602, 10.1093/jnci/djp410 Basch, 2009, Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes, J Natl Cancer Inst, 101, 1624, 10.1093/jnci/djp386 Bruner, 2012, 139 Groenvold, 2007, Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff, Breast Cancer Res Treat, 103, 185, 10.1007/s10549-006-9365-y Quinten, 2011, Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival, J Natl Cancer Inst, 103, 1851, 10.1093/jnci/djr485 Stephens, 1997, Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?, Qual Life Res, 6, 225, 10.1023/A:1026458604826 http://abstracts.ncri.org.uk/abstract/a-comparison-of-clinician-versus-patient-reported-outcomes-proms-for-late-normal-tissue-side-effects-following-breast-radiotherapy-results-of-the-cambridge-breast-intensity-modulated-radiotherapy-3/. Kaija, 1997, Consistency of patient- and doctor-assessed cosmetic outcome after conservative treatment of breast cancer, Breast Cancer Res Treat, 45, 225, 10.1023/A:1005853419167 Hoeller, 2003, Cosmesis from the patient's and the doctor's view, Int J Radiat Oncol Biol Phys, 57, 345, 10.1016/S0360-3016(03)00589-3 Kirchheiner, 2012, Do clinicians and patients agree regarding symptoms? A comparison after definitive radiochemotherapy in 223 uterine cervical cancer patients, Strahlenther Onkol, 188, 933, 10.1007/s00066-012-0156-6 Bruner, 2011, Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE), Trans Behav Med, 1, 110, 10.1007/s13142-011-0025-3 Corner, 2013, Qualitative analysis of patients' feedback from a PROMs survey of cancer patients in England, BMJ Open, 3, 10.1136/bmjopen-2012-002316 Andreassen, 2012, Conducting radiogenomic research – do not forget careful consideration of the clinical data, Radiother Oncol, 105, 337, 10.1016/j.radonc.2012.11.004